Aligos Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Aligos Therapeutics has a total shareholder equity of $67.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $108.8M and $41.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$94.54m |
| Equity | US$67.23m |
| Total liabilities | US$41.58m |
| Total assets | US$108.81m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 5WK0's short term assets ($99.6M) exceed its short term liabilities ($23.6M).
Long Term Liabilities: 5WK0's short term assets ($99.6M) exceed its long term liabilities ($18.0M).
Debt to Equity History and Analysis
Debt Level: 5WK0 is debt free.
Reducing Debt: 5WK0 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 5WK0 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 5WK0 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 9.5% each year